Nicca Chemical Co., Ltd.TSE: 4463

​Summary of Consolidated Financial Results for the Three Months Ended March 31, 2026 (Based on Japanese GAAP)

· Issued by Nicca Chemical Co., Ltd.

Translation

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

Summary of Consolidated Financial Results for the Three Months Ended March 31, 2026 (Based on Japanese GAAP)

April 30, 2026

Company name: NICCA CHEMICAL CO., LTD.

Stock exchange listings: Tokyo, Nagoya

Stock code: 4463

URL: https://www.nicca.co.jp

Representative: Yasumasa Emori, President and Representative Director

Contact: Shoya Sawasaki, Director, Member of the Board, Head of Administration Unit

TEL: +81-776-24-0213(main)

Scheduled date for dividend payment: -

Supplementary materials for financial summaries:

Yes

Financial results briefing: None

(Amounts less than one million yen are rounded down)

  1. Consolidated Financial Results for the Three Months of the Fiscal Year Ending December 31, 2026 (from January 01, 2026 to March 31, 2026)
    1. Consolidated operating results (Cumulative) (Percentage indicate YoY changes)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Three months ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      March 31, 2026

      15,017

      13.8

      1,159

      35.4

      1,176

      46.2

      919

      214.0

      March 31, 2025

      13,195

      7.9

      856

      45.6

      804

      5.0

      292

      (8.0)

      (Note) 1. Comprehensive income

      For the three months ended December 31, 2026: 1,109 million yen (-%) For the three months ended December 31, 2025: (1,141) million yen (-%)

      Basic earnings per share

      Diluted earnings per share

      Three months ended

      Yen

      Yen

      March 31, 2026

      57.78

      -

      March 31, 2025

      18.50

      -

    2. Consolidated financial positions

      Total assets

      Net assets

      Equity ratio

      Net assets per share

      As of

      Millions of yen

      Millions of yen

      %

      Yen

      March 31, 2026

      76,973

      38,873

      46.4

      2,241.81

      December 31, 2025

      74,052

      38,354

      47.5

      2,211.79

      (Reference) Owner's equity

      As of the first quarter of the fiscal year ending December 2026: 35,693 million yen As of the fiscal year ended December 2025: 35,202 million yen

  2. Cash dividends

    Annual dividends per share

    End of first quarter

    End of second quarter

    At the end of the third quarter

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended

    December 31, 2025

    -

    30.00

    -

    30.00

    60.00

    Fiscal year ending December 31, 2026

    -

    Fiscal year ending December 31, 2026

    (Forecast)

    35.00

    -

    35.00

    70.00

    (Note) Presence or absence of revisions from the most recently announced dividend forecast: None

  3. Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2026 (from January 01, 2026 to December 31,
2026)

(Percentages indicate YoY changes)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Fiscal year ending December 31, 2026

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

58,500

5.0

4,200

9.2

4,050

5.2

2,800

17.4

176.47

(Note) Correction of financial forecast from the most recent financial forecast: None

  • Notes

    1. Significant changes in the scope of consolidation during the period: None

    2. Application of specific accounting for the consolidated quarterly financial statements: Yes

    3. Changes in accounting policies, changes in accounting estimates, retrospective restatement

      1. Changes in accounting policies due to revisions of accounting standards : None

      2. Changes in accounting policies other than (i): None

      3. Changes in accounting estimates : None

      4. Retrospective restatement : None

    4. Number of shares issued (common stock)

      1. Total number of issued shares at the end of the period (including treasury shares)

        As of March 31, 2026

        17,710,000 shares

        As of December 31, 2025

        17,710,000 shares

      2. Number of treasury shares at the end of the period

        As of March 31, 2026

        1,788,463 shares

        As of December 31, 2025

        1,794,367 shares

      3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

      Three months ended March 31, 2026

      15,918,859 shares

      Three months ended March 31, 2025

      15,834,645 shares

  • Review of attached consolidated quarterly financial statements by a certified public accountant or an audit firm: None

  • Notes on the appropriate use of forecasts and other special items (Cautionary Statement Regarding Forward-Looking Statements)

Forward-looking statements such as earnings forecasts contained in this document are based on information currently available to the Company and on certain assumptions that are deemed reasonable. They are not intended as a guarantee of achievement by the Company. Actual results may differ significantly due to various factors in the future.

Table of Contents for Attached Materials

  1. Overview of Operating Results, etc. 2

    1. Overview of Operating Results for the Current Quarter 2

    2. Overview of Financial Position for the Current Quarter 3

    3. Explanation of Consolidated Financial Forecasts and Other Forward-looking Information 3

  2. Quarterly Consolidated Financial Statements and Main Notes 4

    1. Quarterly Consolidated Balance Sheet 4

    2. Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income 6

    3. Notes to Quarterly Consolidated Financial Statements 8

(Notes on Accounting Treatment Specific to the Preparation of Quarterly Consolidated Financial

Statements) 8

(Notes on Segment Information, etc.) 9

(Notes in case of significant changes in the amount of shareholders' equity) 11

(Notes regarding the assumption of a going concern) 11

(Notes on the quarterly consolidated statement of cash flows) 11

  1. Overview of Operating Results, etc.

    1. Overview of Operating Results for the Current Quarter

      During the first quarter of the current consolidated fiscal year (from January 1, 2026 to March 31, 2026), the global economy remained in an extremely complex and uncertain situation, as rising geopolitical risks, including escalating tensions in the Middle East, made the impact on the global economy of movements in raw material and energy prices, exchange rate fluctuations, and overseas economic trends highly uncertain. In addition, although the Japanese economy continued on a moderate recovery trend, with signs of a pickup in personal consumption and capital investment, there are concerns about the impact that the situation in the Middle East and other factors may have on the domestic economy going forward.

      Against this backdrop, under the corporate purpose of "Activate Your Life" and the management vision of "To be the most respected innovation company for customers all over the world," the Group formulated "INNOVATION30" (2026-2030), a medium-term business plan setting forth specific strategies through 2030, and established the following basic strategies: "Business expansion and growth investment," "Strengthening financial and capital strategies," and "Sustainability management." Going forward, we will continue to transform the rapidly changing business environment into business opportunities and strive for sustainable growth by focusing on businesses that provide value increasingly needed by society.

      For the first quarter of the fiscal year ending December 31, 2026, net sales were 15,017 million yen (up 13.8% year on year), operating profit was 1,159 million yen (up 35.4% year on year), ordinary profit was 1,176 million yen (up 46.2% year on year), and profit attributable to owners of parent was 919 million yen (up 214.0% year on year).

      Segment results were as follows. Net sales for each segment do not include intersegment sales. (Chemicals Business)

      The Chemicals business includes, in addition to the Group's mainstay textile chemicals, chemicals for information recording

      paper, resin raw materials, industrial cleaning agents, chemicals for medical and nursing care facilities, and other functional chemicals.

      Net sales were 11,530 million yen (up 18.5% year on year), and segment profit was 1,499 million yen (up 39.0% year on year). In the core textile chemicals business, sales increased mainly at the China bases due to progress in winning new business for high-value-added EHD-related products such as PFC-free Durable Water Repellent and process chemicals. In addition, sales also increased in Southwest Asia and South Korea. Sales of process chemicals for electronic materials also increased due to the acquisition of new business. As a result of this sales growth, although selling, general and administrative expenses increased, the Chemicals business posted increases in both sales and profit, and net sales, segment profit, and segment profit margin for the first quarter reached record highs.

      (Cosmetics Business)

      The Cosmetics business mainly handles hair care products, hair color products, perm products, scalp care products, and styling products.

      Net sales were 3,287 million yen (down 0.4% year on year), and segment profit was 187 million yen (down 28.5% year on year). At DEMI Cosmetics, although key brands performed steadily, results were affected by the domestic economy, including rising prices. Among consolidated subsidiaries, sales at DEMI KOREA CO.,LTD. decreased due to worsening market conditions, while the contract manufacturing business at Yamada Pharmaceutical Co., Ltd. remained steady. Meanwhile, due to strategic cost increases at DEMI Cosmetics and other factors, the Cosmetics business posted decreases in both sales and profit.

      (Others)

      Net sales were 199 million yen (up 22.2% year on year), and segment loss was 20 million yen (compared with segment profit of 8 million yen in the same period of the previous year).

    2. Overview of Financial Position for the Current Quarter (Assets)

      Total assets at the end of the first quarter of the current fiscal year increased by 2,921 million yen from the end of the previous fiscal year to 76,973 million yen. This was mainly due to increases of 2,066 million yen in other intangible assets, 369 million yen in merchandise and finished goods, and 478 million yen in raw materials and supplies.

      (Liabilities)

      Total liabilities at the end of the first quarter of the current fiscal year increased by 2,402 million yen from the end of the previous fiscal year to 38,100 million yen. This was mainly due to an increase of 2,595 million yen in other current liabilities and an increase of 524 million yen in the current portion of long-term borrowings, while long-term borrowings decreased by 616 million yen.

      (Net assets)

      Total net assets at the end of the first quarter of the current consolidated fiscal year increased by 518 million yen from the end of the previous consolidated fiscal year to 38,873 million yen. This was mainly due to a 919 million yen increase in retained earnings resulting from the recording of quarterly profit attributable to owners of parent, while retained earnings decreased by 490 million yen due to the payment of dividends.

    3. Explanation of Consolidated Financial Forecasts and Other Forward-looking Information

      Although rising raw material prices and various costs, supply chain disruptions, and other issues have occurred due to heightened tensions in the Middle East, the Company has not revised its consolidated financial forecasts at this time because the future outlook remains uncertain and difficult to predict.

      The Company plans to continue implementing price revisions and cost reduction activities while closely monitoring future developments.

      In addition, if it becomes necessary to revise the financial forecasts, the Company plans to disclose such revisions promptly.

  2. Quarterly Consolidated Financial Statements and Main Notes

    1. Quarterly Consolidated Balance Sheet

      (Unit: Millions of yen)

      Previous fiscal year (December 31, 2025)

      For the three months ended (March 31, 2026)

      Assets

      Current assets

      Cash and deposit

      11,848

      11,765

      Notes and accounts receivable - trade, and contract assets

      11,955

      12,048

      Merchandise and finished goods

      5,446

      5,815

      Work in process

      919

      762

      Raw materials and supplies

      4,638

      5,116

      Other

      920

      1,244

      Allowance for doubtful accounts

      (13)

      (13)

      Total current asset

      35,715

      36,740

      Non-current assets

      Property, plant, and equipment

      Buildings and structures, net

      11,704

      11,489

      Machinery, equipment and vehicles, net

      2,058

      1,921

      Land

      7,807

      7,794

      Construction in progress

      11,382

      11,473

      Other (net)

      682

      702

      Total property, plant and equipment, net

      33,635

      33,381

      Intangible assets

      Other

      933

      2,999

      Total intangible assets

      933

      2,999

      Investment Other assets

      Other

      3,767

      3,851

      Total investment and other assets

      3,767

      3,851

      Total non-current assets

      38,336

      40,233

      Total assets

      74,052

      76,973

      (Unit: Millions of yen)

      Previous fiscal year (December 31, 2025)

      For the three months ended (March 31, 2026)

      Liabilities

      Current liabilities

      Notes and accounts payable - trade

      6,335

      6,224

      Short-term borrowings

      9,302

      9,395

      Current portion of long-term borrowings

      1,368

      1,892

      Income taxes payable

      388

      417

      Provision for bonuses

      1,046

      447

      Provision for bonuses for directors

      20

      4

      Other

      4,522

      7,117

      Total current liabilities

      22,983

      25,498

      Non-current liabilities

      Long-term borrowings

      7,866

      7,250

      Liabilities for retirement benefits

      3,262

      3,265

      Provision for share-based payments

      274

      276

      Other

      1,310

      1,809

      Total non-current liabilities

      12,713

      12,601

      Total liabilities

      35,697

      38,100

      Net assets

      Shareholders' equity

      Share capital

      2,898

      2,898

      Capital surplus

      3,061

      3,061

      Retained earnings

      25,712

      26,142

      Treasury shares

      (1,401)

      (1,394)

      Total shareholders' equity

      30,271

      30,707

      Accumulated other comprehensive income

      Valuation difference on available-for-sale securities

      829

      788

      Foreign currency translation adjustment

      4,445

      4,533

      Remeasurements of defined benefit plans

      (343)

      (336)

      Total accumulated other comprehensive income

      4,931

      4,985

      Non-controlling interests

      3,152

      3,180

      Total net assets

      38,354

      38,873

      Total liabilities and net assets

      74,052

      76,973

    2. Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income (Quarterly Consolidated Statement of Income)

      (Unit: Millions of yen)

      For the three months ended [previous period]

      From January 1, 2025

      Until March 31, 2025

      For the three months ended From January 1, 2026

      Until March 31, 2026

      Net sales

      13,195

      15,017

      Cost of sales

      8,413

      9,626

      Gross profit

      4,782

      5,391

      Selling, general and administrative expenses

      3,926

      4,231

      Operating profit

      856

      1,159

      Non-operating income

      Interest income

      24

      25

      Dividend income

      3

      4

      Share of income of investments accounted for using the equity method

      1

      7

      Other

      41

      49

      Total non-operating income

      70

      87

      Non-operating expenses

      Interest expense

      26

      57

      Foreign exchange losses

      73

      2

      Other

      22

      10

      Total non-operating expenses

      122

      70

      Ordinary profit

      804

      1,176

      Extraordinary income

      Gain on sale of non-current assets

      0

      -

      Gain on sale of investment securities

      -

      9

      Gain on bargain purchase

      -

      7

      Total extraordinary income

      0

      16

      Extraordinary losses

      Loss on retirement of fixed assets

      0

      1

      Loss on sale of non-current assets

      0

      -

      Total extraordinary losses

      1

      1

      Net income before income taxes

      803

      1,191

      Income taxes

      425

      162

      Net income

      378

      1,029

      Net income attributable to non-controlling interests

      85

      109

      Profit attributable to owners of parent

      292

      919

      (Quarterly Consolidated Statement of Comprehensive Income)

      (Unit: Millions of yen)

      For the three months ended [previous period]

      From January 1, 2025

      Until March 31, 2025

      For the three months ended From January 1, 2026

      until March 31, 2026

      Net income

      378

      1,029

      Other comprehensive income (loss), net of tax

      Valuation difference on available-for-sale securities

      (119)

      (41)

      Foreign currency translation adjustment

      (1,390)

      114

      Remeasurements of defined benefit plans, net of tax

      (9)

      6

      Other comprehensive income, net of tax

      (1,519)

      80

      Comprehensive income

      (1,141)

      1,109

      Comprehensive income attributable to

      Quarterly comprehensive income attributable to owners of the parent

      (1,050)

      973

      Quarterly comprehensive income attributable to non-controlling interests

      (90)

      135

    3. Notes to Quarterly Consolidated Financial Statements

      (Notes on Accounting Treatment Specific to the Preparation of Quarterly Consolidated Financial Statements) (Calculation of tax expenses)

      Income taxes are calculated by reasonably estimating the effective tax rate after applying tax-effect accounting to profit before income taxes for the consolidated fiscal year including the first quarter of the current consolidated fiscal year, and multiplying quarterly profit before income taxes by such estimated effective tax rate. However, if calculating income taxes using such estimated effective tax rate would result in a markedly unreasonable outcome, the statutory effective tax rate is used.

      (Notes on Segment Information, etc.) [Segment Information]

      I For the three months ended March 31, 2025

      1. Information on net sales and profit or loss by reportable segment

        (Unit: Millions of yen)

        Reportable segment

        Other (Note)

        Total

        Chemicals Business

        Cosmetics Business

        Total

        Net sales

        Net sales to external customers

        9,730

        3,300

        13,031

        163

        13,195

        Internal net sales between segments or transfer amount

        -

        1

        1

        23

        24

        Total

        9,730

        3,301

        13,032

        186

        13,219

        Segment profit or loss (-)

        1,078

        262

        1,340

        8

        1,349

        (Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment installation contracts.

      2. Difference between the total amount of profit or loss of reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main components of such difference

        (Matters related to variance adjustments)

        (Unit: Millions of yen)

        Profit

        Amount

        Total for reportable segments

        1,340

        Profit or loss (-) in the "Other" category

        8

        Elimination of inter-segment transactions

        21

        Company-wide expenses (Note)

        (514)

        Quarterly Consolidated Statement of Income Operating profit

        856

        (Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.

      3. Information on impairment losses of non-current assets or goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)

There are no applicable matters.

(Significant changes in the amount of goodwill) There are no applicable matters.

(Significant gain on bargain purchase) There are no applicable matters.

II For the three months ended March 31, 2026

  1. Information on net sales and profit or loss by reportable segment

    (Unit: Millions of yen)

    Reportable segments

    Other (Note)

    Total

    Chemicals Business

    Cosmetics Business

    Total

    Net sales

    Net sales to external customers

    11,530

    3,287

    14,817

    199

    15,017

    Internal net sales between segments or transfer amount

    0

    0

    0

    16

    17

    Total

    11,530

    3,288

    14,818

    216

    15,035

    Segment profit or loss (-)

    1,499

    187

    1,687

    (20)

    1,666

    (Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment contracting work.

  2. The difference between the total amount of profit or loss for reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main components of such difference

    (Matters related to variance adjustments)

    (Unit: Millions of yen)

    Profit

    Amount

    Total for reportable segments

    1,687

    Profit or loss (-) in the "Other" category

    (20)

    Elimination of inter-segment transactions

    26

    Company-wide expenses (Note)

    (533)

    Quarterly Consolidated Statement of Income Operating profit

    1,159

    (Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.

  3. Information on impairment losses of non-current assets or goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)

There are no applicable matters.

(Significant changes in the amount of goodwill) There are no applicable matters.

(Significant gain on bargain purchase)

Information regarding Gain on bargain purchase by reportable segment is omitted as the amounts are not material. Note that Gain on bargain purchase is classified as extraordinary income and is not included in the segment profit figures above.

(Notes in case of significant changes in the amount of shareholders' equity) There are no applicable matters.

(Notes regarding the assumption of a going concern) There are no applicable matters.

(Notes on quarterly consolidated statement of cash flows)

A quarterly consolidated statement of cash flows for the first quarter of the current fiscal year has not been prepared. In addition, depreciation and amortization (including amortization of intangible assets other than goodwill) for the first quarter of the current

fiscal year are as follows.

For the three months ended [previous period] From January 1, 2025 until March 31, 2025

For the three months ended

From January 1, 2026 until March 31, 2026

Depreciation 523 million yen 497 million yen

Company analysis

Earlier from Nicca Chemical

All Nicca Chemical news releases